Related references
Note: Only part of the references are listed.Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model
Cristina A. Metildi et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
Badreddin Edris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial
Heikki Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
Martin D. McCarter et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Fluorescence-Guided Surgery Allows for More Complete Resection of Pancreatic Cancer, Resulting in Longer Disease-Free Survival Compared with Standard Surgery in Orthotopic Mouse Models
Cristina A. Metildi et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate
Chandrajit P. Raut et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Towards global consensus in the treatment of gastrointestinal stromal tumor
Peter Reichardt et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
Emilia S. Olson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Randomized Clinical Trials in Gastrointestinal Stromal Tumors
Peter A. Learn et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665
Burton L. Eisenberg et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P. DeMatteo et al.
LANCET (2009)
In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation
Hiroyuki Kishimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer
Sharmeela Kaushal et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation
Michele McElroy et al.
WORLD JOURNAL OF SURGERY (2008)
Gastrointestinal stromal tumour
Brian P. Rubin et al.
LANCET (2007)
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
Chandrajit P. Raut et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A knock-in mouse model of gastrointestinal stromal tumor harboring Kit K641E
BP Rubin et al.
CANCER RESEARCH (2005)
Gastrointestinal stromal tumors:: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era -: A population-based study in western Sweden
B Nilsson et al.
CANCER (2005)
Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases
Z Orosz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2005)
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
T Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
KIT-negative gastrointestinal stromal tumors - Proof of concept and therapeutic implications
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
M Miettinen et al.
EUROPEAN JOURNAL OF CANCER (2002)
Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
RP DeMatteo et al.
ANNALS OF SURGERY (2000)